Cover Image

Assessing the Contributions of Inactivation, Removal, and Transfer of Ebola Virus and Vesicular Stomatitis Virus by Disinfectant Pre-soaked Wipes

Disinfectant pre-soaked wipes (DPW) containing activated hydrogen peroxide (AHP) or quaternary ammonium compounds (QAC) were tested using ASTM E2967-15 to determine removal, transfer, and inactivation of Ebola virus Makona variant (EBOV/Mak) and vesicular stomatitis virus (VSV) from contaminated sta...

Full description

Saved in:

Bibliographic Details
Main Authors:	Todd A. Cutts (Author), Catherine Robertson (Author), Steven S. Theriault (Author), Raymond W. Nims (Author), Samantha B. Kasloff (Author), Joseph R. Rubino (Author), M. Khalid Ijaz (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of the Efficacy of Disinfectant Pre-impregnated Wipes for Decontaminating Stainless Steel Carriers Experimentally Inoculated With Ebola Virus and Vesicular Stomatitis Virus
by: Todd A. Cutts, et al.
Published: (2021)

Hand hygiene: virucidal efficacy of a liquid hand wash product against Ebola virus
by: T.A. Cutts, et al.
Published: (2021)

The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
by: Ellen Suder, et al.
Published: (2018)

Tamoxifen Protects from Vesicular Stomatitis Virus Infection
by: Lamin B. Cham, et al.
Published: (2019)

Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus.
by: Chad E Mire, et al.
Published: (2013)

Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
by: Anahita Fathi, et al.
Published: (2019)

Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.
by: Chad E Mire, et al.
Published: (2012)

Limited Effects of Type I Interferons on Kyasanur Forest Disease Virus in Cell Culture.
by: Bradley W M Cook, et al.
Published: (2016)

A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
by: David Safronetz, et al.
Published: (2015)

Immunogenicity of mucosal COVID-19 vaccine candidates based on the highly attenuated vesicular stomatitis virus vector (VSVMT) in golden syrian hamster
by: Yong Ke, et al.
Published: (2023)

West Nile virus encephalitis presenting with a vesicular dermatitis
by: Eunice E. Lee, BS, et al.
Published: (2024)

Diagnostics of Ebola virus
by: Aurora Bettini, et al.
Published: (2023)

Heat inactivation of foot-and-mouth disease virus, swine vesicular disease virus and classical swine fever virus when air-dried on plastic and glass surfaces
by: Thea Kristensen, et al.
Published: (2021)

Virus del Ébola (EVE)
by: Hugo Luis Pizzi
Published: (2015)

Virus Bioinformatics
by: Robertson, David
Published: (2020)

Ebola virus confirmed as cause of outbreak
Published: (2003)

Transmission of Ebola Virus Disease: An Overview
by: Suresh Rewar, et al.
Published: (2015)

The Hemorrhagic Fever: Ebola and Other Viruses
by: Faraz Ahmed Baig, et al.
Published: (2024)

Prognostic Analysis of Patients with Ebola Virus Disease.
by: Xin Zhang, et al.
Published: (2015)

Predicting Ebola Severity: A Clinical Prioritization Score for Ebola Virus Disease.
by: Mary-Anne Hartley, et al.
Published: (2017)

Disinfection of Ebola Virus in Sterilized Municipal Wastewater.
by: Kyle Bibby, et al.
Published: (2017)

Closer than ever to an Ebola virus vaccine
by: Logan Banadyga, et al.
Published: (2017)

Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates
by: John J. Suschak, et al.
Published: (2019)

Pre-Ebola virus disease laboratory system and related challenges in Liberia
by: Stephen B. Kennedy, et al.
Published: (2016)

Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study
by: Daouda Sissoko, MD, et al.
Published: (2017)

Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.
by: Anna Bratcher, et al.
Published: (2021)

Predicting Ebola infection: A malaria-sensitive triage score for Ebola virus disease.
by: Mary-Anne Hartley, et al.
Published: (2017)

Seroprevalence of Ebola virus infection in Bombali District, Sierra Leone
by: Nadege Goumkwa Mafopa, et al.
Published: (2017)

Fruit-all dewaxing wipes / The Amethyst
by: The Amethyst, Kolej Matrikulasi Selangor
Published: (2020)

Approaches to Safety Evaluation of Baby Wipes
by: Ning Li PhD, et al.
Published: (2022)

The laboratory health system and its response to the Ebola virus disease outbreak in Liberia
by: Stephen B. Kennedy, et al.
Published: (2016)

Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection.
by: Xiangguo Qiu, et al.
Published: (2012)

A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus.
by: Yoshimi Tsuda, et al.
Published: (2011)

Development of risk reduction behavioral counseling for Ebola virus disease survivors enrolled in the Sierra Leone Ebola Virus Persistence Study, 2015-2016.
by: Neetu Abad, et al.
Published: (2017)

Correction: Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.
by: Anna Bratcher, et al.
Published: (2022)

Implementation of a study to examine the persistence of Ebola virus in the body fluids of Ebola virus disease survivors in Sierra Leone: Methodology and lessons learned.
by: Gibrilla Fadlu Deen, et al.
Published: (2017)

Experimental vaccine protects monkeys against Ebola virus
by: Scott Gottlieb

Meta-analysis of predictive symptoms for Ebola virus disease.
by: Vageesh Jain, et al.
Published: (2020)

Characterization of the catalytic center of the Ebola virus L polymerase.
by: Marie Luisa Schmidt, et al.
Published: (2017)

Risk assessment of Ebola Reston virus in humans in the Philippines
by: Johnette A Peñas, et al.
Published: (2019)